LifeVantageLFVN
LFVN
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
1,696% more call options, than puts
Call options by funds: $2.21M | Put options by funds: $123K
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
60% more capital invested
Capital invested by funds: $45.6M [Q3] → $72.9M (+$27.3M) [Q4]
57% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 14
15% more funds holding
Funds holding: 67 [Q3] → 77 (+10) [Q4]
2.57% more ownership
Funds ownership: 30.62% [Q3] → 33.19% (+2.57%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for LFVN.
Financial journalist opinion
Neutral
GlobeNewsWire
1 month ago
LifeVantage Expands Global Reach with International Launch of the MB System™
SALT LAKE CITY, March 17, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation ® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets. This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., largely driven by the system's success, and clinical data on that formula reinforcing its effectiveness in supporting GLP-1 production.
Neutral
GlobeNewsWire
1 month ago
LifeVantage Announces Launch of LV360 and Evolve Compensation Plan in Philippines, Taiwan, Hong Kong, and Singapore Markets
SALT LAKE CITY, March 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation ® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful launch of the Evolve Compensation Plan and other LV360 initiatives into the Philippines, Taiwan, Hong Kong, and Singapore. The transition went into effect in these markets on March 1, 2025, after the successful launch of LV360 into Canada, Mexico, and Europe last February, and the launch in the US, Australia, New Zealand and Japan in March 2023.
Positive
MarketBeat
2 months ago
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are permitted when drugs are listed on the FDA's list of drug shortages.
Positive
Seeking Alpha
2 months ago
LifeVantage: Post-Earnings Selloff Provides Buying Opportunity
LifeVantage Corporation's Q2/FY2025 results were boosted by the successful launch of the MindBody GLP-1 system. LFVN revenues jumped by more than 40% on a sequential basis, while free cash flow of $8.7 million represented a new multi-year high. However, elevated commissions and incentive expenses impacted profitability, thus resulting in a rather mediocre Adjusted EBITDA margin of 9.6%.
Neutral
Seeking Alpha
2 months ago
LifeVantage Corporation (LFVN) Q2 2025 Earnings Call Transcript
LifeVantage Corporation (NASDAQ:LFVN ) Q2 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Reed Anderson – Managing Director-ICR Steve Fife – President and Chief Executive Officer Carl Aure – Chief Financial Officer Conference Call Participants Aaron Wukmir – Lake Street Capital Markets Alex Fuhrman – Craig-Hallum Capital Group Doug Lane – Water Tower Research Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Second Quarter of Fiscal 2025 Results.
Neutral
GlobeNewsWire
2 months ago
LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid March 17, 2025 to all stockholders of record at the close of business on March 3, 2025.
Neutral
GlobeNewsWire
2 months ago
LifeVantage to Announce Second Quarter Fiscal Year 2025 Results on February 5, 2025
SALT LAKE CITY, Jan. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2024, after the stock market closes on Wednesday, February 5, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Neutral
GlobeNewsWire
3 months ago
LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer
Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage's growth and digital transformation Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage's growth and digital transformation
Neutral
GlobeNewsWire
3 months ago
LifeVantage Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System™
New Innovations and Incentives Empower Consultants to Accelerate Business Growth in 2025 New Innovations and Incentives Empower Consultants to Accelerate Business Growth in 2025
Positive
Seeking Alpha
3 months ago
Undercovered Dozen: Fannie Mae, Civitas Resources, LifeVantage, ZenaTech +
The 'Undercovered' Dozen series highlights lesser-covered stocks, offering investment ideas and encouraging discussion among investors. Pacifica Yield highlights Brookfield Infrastructure's subordinated notes with a 32% discount opportunity and a 7.2% yield, backed by a strong balance sheet and diversified assets. Cerence Inc.'s partnership with Nvidia boosts its AI capabilities according to Uttam Dey, but caution is advised due to recent stock surge and potential volatility.
Charts implemented using Lightweight Charts™